Development of a test that measures real-time HER2 signaling function in live breast cancer cell lines and primary cells

Overview of attention for article published in BMC Cancer, March 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (82nd percentile)
High Attention Score compared to outputs of the same age and source (89th percentile)

So far, Altmetric has seen 9 X posts from 3 X users, with an upper bound of 3,967 followers.

RT @WillxCELLigence: Patient pre-screening for HER2 targeted therapy. Functional EGF signalling profiler, with #xCELLigence _____ https://…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 5 additional X posts.